Triazolopyridine compounds and uses thereof
US10689378B2 · kind B2 · utility
3Cited by
7References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 2017 |
| Grant date | Jun 23, 2020 |
| Priority date | — |
| Expiry date | Jun 6, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R6, R7 and R8 are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.